An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

Clinical trial NCT07680205 · RECRUITING

Trial details

NCT number: NCT07680205
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pheochromocytoma and Paraganglioma (PPGL)Pheochromocytoma Malignant Pheochromocytoma, Metastatic Pheochromocytoma/Paraganglioma Pheochromocytoma

Start date: 2026-04-27
Primary completion: 2027-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.